DGAP-Adhoc: PlasmaSelect Group sells its Haemaccel® marketing authorizations

| Source: EQS Group AG EQS Group AG 

PlasmaSelect AG / Disposal

02.07.2008 

Release of a Adhoc News, transmitted by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------

The PlasmaSelect Group today sold and transfered its marketing
authorizations, trademarks, export distribution contracts and German
inventories related to its product Haemaccel® to the Indian Piramal
Healthcare Group. The purchase price amounted to approximately 8 million
euros. The PlasmaSelect Group will, for the time being, continue to market
in Germany and Italy and to manufacture the product Haemaccel® for Piramal.
DGAP 02.07.2008 
---------------------------------------------------------------------------
Language:     English
Issuer:       PlasmaSelect AG
              Pettenkoferstraße 22
              80336 München
              Deutschland
Phone:        +49 (0)89 810 29-0
Fax:          +49 (0)89 810 29-111
E-mail:       info@plasmaselect.de
Internet:     www.plasmaselect.de
ISIN:         DE0005471809
WKN:          547180
Listed:       Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
              in Berlin, Stuttgart, München, Hamburg, Düsseldorf
End of News                                     DGAP News-Service
---------------------------------------------------------------------------